Survival Analysis
Impact of social disparities on 10 year survival rates in paediatric cancers: a cohort study - The Lancet Regional Health – Americas
Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review | British Journal of Cancer
A joint international consensus statement for measuring quality of survival for patients with childhood cancer | Nature Medicine
Trial Outcome Measures | Download Table
Overall survival vs disease-free survival and other surrogate endpoints - survival-analysis - Datamethods Discussion Forum
Overall Survival Results with KISQALI® (ribociclib)
JCI Insight - A clinical measure of DNA methylation predicts outcome in de novo acute myeloid leukemia
27 Survival analysis | The Epidemiologist R Handbook
Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects | Nature Communications
The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challenges - The Lancet Regional Health – Western Pacific
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry - The Lancet Regional Health – Europe
Survival in oncology reimbursement decision-making | CMAR
Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and ...
Roche | Ever wondered how patient outcomes are measured in clinical trials?
Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed | Nature Reviews Clinical Oncology
Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study - ScienceDirect
Pulmonary Symptoms Measured by the National Institutes of Health Lung Score Predict Overall Survival, Nonrelapse Mortality, and Patient-Reported Outcomes In Chronic Graft-Versus-Host Disease - Biology of Blood and Marrow Transplantation
Measures of Cancer Survival
Overall Survival Results with KISQALI® (ribociclib)
Abbreviations used for outcome measures | Download Scientific Diagram
Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysis - European Urology Focus
Figure 1, Outcome Measures Framework - Development of Harmonized Outcome Measures for Use in Patient Registries and Clinical Practice: Methods and Lessons Learned - NCBI Bookshelf
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM
